$13.71
1.71%
NYSE, Oct 02, 04:06 pm EDT. Closed.
ISIN
US1638511089
Symbol
CC

Chemours Co. Target price 2026 - Analyst rating & recommendation

Chemours Co. Classifications & Recommendation

Buy
61%
Hold
33%
Sell
6%

Chemours Co. Price Target

Target Price $18.36
Price $13.71
Potential
Number of Estimates 13
13 Analysts have issued a price target Chemours Co. 2027 . The average Chemours Co. target price is $18.36. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 18 analysts: 11 Analysts recommend Chemours Co. to buy, 6 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Chemours Co. stock has an average upside potential 2027 of . Most analysts recommend the Chemours Co. stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 5.81 6.10
0.45% 4.96%
EBITDA Margin 5.77% 13.47%
54.69% 133.53%
Net Margin -6.65% 2.57%
656.92% 138.67%

13 Analysts have issued a sales forecast Chemours Co. 2026 . The average Chemours Co. sales estimate is

$6.1b
unlock
. This is
5.16% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.2b 7.73%
unlock
, the lowest is
$5.8b 0.78%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $5.8b 0.45%
2026
$6.1b 4.96%
unlock
2027
$6.4b 4.54%
unlock
2028
$6.6b 3.59%
unlock

13 Analysts have issued an Chemours Co. EBITDA forecast 2026. The average Chemours Co. EBITDA estimate is

$821m
unlock
. This is
235.14% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$855m 249.07%
unlock
, the lowest is
$764m 211.88%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $335m 54.48%
2026
$821m 145.10%
unlock
2027
$960m 16.97%
unlock
2028
$1.0b 7.97%
unlock

EBITDA Margin

2025 5.77% 54.69%
2026
13.47% 133.53%
unlock
2027
15.07% 11.88%
unlock
2028
15.71% 4.25%
unlock

13 Chemours Co. Analysts have issued a net profit forecast 2026. The average Chemours Co. net profit estimate is

$156m
unlock
. This is
151.44% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$190m 162.36%
unlock
, the lowest is
$112m 136.86%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-386m 659.42%
2026
$156m 140.52%
unlock
2027
$299m 91.12%
unlock
2028
$362m 21.06%
unlock

Net Margin

2025 -6.65% 656.92%
2026
2.57% 138.67%
unlock
2027
4.69% 82.49%
unlock
2028
5.48% 16.84%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -2.57 1.04
658.70% 140.47%
P/E 13.19
EV/Sales 0.86

13 Analysts have issued a Chemours Co. forecast for earnings per share. The average Chemours Co. EPS is

$1.04
unlock
. This is
151.74% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$1.26 162.69%
unlock
, the lowest is
$0.74 136.82%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-2.57 658.70%
2026
$1.04 140.47%
unlock
2027
$1.99 91.35%
unlock
2028
$2.40 20.60%
unlock

P/E ratio

Current -6.82 21.96%
2026
13.19 293.38%
unlock
2027
6.90 47.69%
unlock
2028
5.70 17.39%
unlock

Based on analysts' sales estimates for 2026, the Chemours Co. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.91 10.78%
2026
0.86 5.10%
unlock
2027
0.83 4.35%
unlock
2028
0.80 3.46%
unlock

P/S ratio

Current 0.36 10.76%
2026
0.34 4.89%
unlock
2027
0.32 4.34%
unlock
2028
0.31 3.49%
unlock

Current Chemours Co. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Mizuho
Locked
➜
Locked
Locked Sep 30 2026
BMO Capital
Locked
➜
Locked
Locked Aug 13 2026
JP Morgan
Locked
➜
Locked
Locked Aug 13 2026
UBS
Locked
➜
Locked
Locked Aug 10 2026
RBC Capital
Locked
➜
Locked
Locked Aug 06 2026
Truist Securities
Locked
➜
Locked
Locked Aug 06 2026
Mizuho
Locked
➜
Locked
Locked Jul 01 2026
Analyst Rating Date
Locked
Mizuho:
Locked
➜
Locked
Sep 30 2026
Locked
BMO Capital:
Locked
➜
Locked
Aug 13 2026
Locked
JP Morgan:
Locked
➜
Locked
Aug 13 2026
Locked
UBS:
Locked
➜
Locked
Aug 10 2026
Locked
RBC Capital:
Locked
➜
Locked
Aug 06 2026
Locked
Truist Securities:
Locked
➜
Locked
Aug 06 2026
Locked
Mizuho:
Locked
➜
Locked
Jul 01 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today